[Federal Register Volume 71, Number 211 (Wednesday, November 1, 2006)]
[Notices]
[Page 64298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-18431]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Prior to issuing a registration under 21 U.S.C. 952(a)(2)(B), and 
in accordance with 21 CFR 1301.34(a), this is notice that on July 25, 
2006, Alcan Packaging-Bethlehem, 2400 Baglyos Circle, Bethlehem, 
Pennsylvania, 18020, has made application to the Drug Enforcement 
Administration (DEA) to be registered as an importer of Nabilone 
(7379), a basic class of controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
packaging and for distribution.
    Any manufacturer who is presently, or is applying to be, registered 
with DEA to manufacture such basic class of controlled substance may 
file comments or objections to the issuance of the proposed 
registration and may, at the same time, file a written request for a 
hearing on such application pursuant to 21 CFR 1301.43 and in such form 
as prescribed by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than December 1, 2006.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e), and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic class of any controlled substance listed 
in schedule I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: October 25, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-18431 Filed 10-31-06; 8:45 am]
BILLING CODE 4410-09-P